Skip to main content

Table 2 Primary and secondary outcomes of DigiSep-trial

From: Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)—study protocol for a randomized, controlled, interventional, open-label, multicenter trial

Outcomes

Data source

Timepoint/frame

Primary outcomes

DOOR/RADAR score

eCRF

28 days

Secondary outcomes

Long term mortality

Statutory health insurance data, eCRF

90, 180 days

Degree of organ dysfunction/failure:

• Duration of mechanical ventilation

• Length of time until shock resolution

• Ongoing RRT-dependency

eCRF

28, 90, 180 days

Hospital length of stay

Statutory health insurance data, eCRF

28, 90, 180 days

Cumulative need for anti-infective drugs

Statutory health insurance data, eCRF

28, 90, 180 days

Beginning of a targeted anti-infective treatment regimen

eCRF

28 days

Resource utilization (outpatient and inpatient)

Statutory health insurance data

28, 90, 180 days

Duration and costs of incapacity to work

Statutory health insurance data

28, 90, 180 days

Direct medical costs (outpatient and inpatient)

Statutory health insurance data

28, 90, 180 days

Quality-of-life (QoL)

VR-36 questionnaire

0, 90, 180 days

  1. Abbreviations: RRT renal replacement therapy; QoL quality of life; eCRF electronic case report from; DOOR/RADAR score Desirability of Outcome Ranking/Response Adjusted for Duration of Antibiotic Risk score